Why the study?
Does laparoscopic elective radical rectal cancer resection have safe short-term and long-term outcomes in octogenarians compared to younger patients?
Does laparoscopic elective radical rectal cancer resection have safe short-term and long-term outcomes in octogenarians compared to younger patients?
Laparoscopic rectal cancer resection in octogenarians is associated with higher cardiopulmonary complications and lower 5-year survival compared to younger patients, indicating a need for careful patient selection and preoperative assessment.
Answers are grounded in this paper and cite their sources.
Associated with higher cardiopulmonary complications and lower survival in octogenarians; leaves open whether refined preoperative selection improves outcomes.
The aim of our study is to assess short-term and long-term outcomes after laparoscopic radical rectal cancer resection in octogenarians compared with those in patients 60 years old or younger. Methods: Using a prospectively collected database of laparoscopic colorectal resections by a single surgeon from March 2001 to December 2012, we retrospectively reviewed 49 octogenarian rectal cancer patients and 63 younger counterparts. Results: The American Society of Anesthesiologists (ASA) score (P< 0.001), history of previous abdominal surgery (P= 0.019), preoperative prevalence of other malignancy (P= 0.001), perioperative transfusion (P= 0.032), and cardiorespiratory comorbidities (P< 0.001) were significantly higher in octogenarians. No difference existed between two groups in terms of preoperative chemoradiation rate, surgical procedures, distal and radial resection margin, harvested lymph node number, and tumor node metastasis (TNM) staging. The rates of at least one complication (P= 0.019), postoperative ileus (P= 0.006) and cardiopulmonary complication (P= 0.021) were higher in octogenarians, but rates of leakage and reoperation were not high. During median follow-up of 53 months, one pelvic recurrence developed in octogenarians. The overall 5-year survival rate was 63.9% in octogenarians and 93.7% in younger patients (P< 0.001). Two-year disease free survival rate for pathologic stage III in octogenarians was 51.0%, much lower (P= 0.008), but not so for stage 0-II than in younger patients.
No takes yet. Share an insight, caveat, or question.
Park et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: